Augmenting the potency of breast cancer vaccines: combined modality immunotherapy.

Abstract

Rapid progress in defining the molecular underpinnings of the antitumor immune response has laid the foundation for tumor immunotherapy, leading to multiple early clinical studies testing vaccines for the treatment of breast cancer. Together, these small trials have provided early evidence for the induction of clinically relevant vaccine-induced tumor… (More)

Topics

Cite this paper

@article{Emens2004AugmentingTP, title={Augmenting the potency of breast cancer vaccines: combined modality immunotherapy.}, author={Leisha A. Emens and Richard T. Reilly and Elizabeth M. Jaffee}, journal={Breast disease}, year={2004}, volume={20}, pages={13-24} }